C

Clearside Biomedical
D

CLSD

0.83160
USD
-0.06
(-6.53%)
مغلق
حجم التداول
10,466
الربح لكل سهم
-0
العائد الربحي
-
P/E
-2
حجم السوق
64,152,844
أصول ذات صلة
C
CRSP
0.290
(0.90%)
32.400 USD
C
CRVS
0.13000
(4.68%)
2.91000 USD
E
EDIT
-0.05400
(-5.24%)
0.97600 USD
N
NTLA
-0.40000
(-6.04%)
6.22000 USD
R
RGNX
-0.46300
(-7.36%)
5.83000 USD
S
SGMO
-0.03410
(-5.17%)
0.62570 USD
V
VCEL
-1.820
(-4.36%)
39.900 USD
المزيد
الأخبار المقالات

العنوان: Clearside Biomedical

القطاع: Healthcare
الصناعة: Biotechnology
Clearside Biomedical Inc is a United States-based clinical biopharmaceutical company. It is engaged in developing pharmacological therapies to treat blinding disease of the eye through the suprachoroidal space, or SCS. The company's novel SCS injection platform, utilizing a proprietary SCS Microinjector, enables an in-office, repeatable, non-surgical procedure for the targeted and compartmentalized delivery of a wide variety of therapies to the macula, retina, or choroid to potentially preserve and improve vision in patients with sight-threatening eye diseases.